Post, F. A., Wohl, D., Liegeon, G., Brar, I., Hagins, D., Yazdanpanah, Y., . . . Hindman, J. T. (2026). Renal Outcomes in People With HIV-1 and Renal Impairment Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide: Integrated Analysis From 9 Phase 3/3b Clinical Trials. Open Forum Infectious Diseases, 13(5), 1. https://doi.org/10.1093/ofid/ofag265
Chicago Style (17th ed.) CitationPost, Frank A., et al. "Renal Outcomes in People With HIV-1 and Renal Impairment Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide: Integrated Analysis From 9 Phase 3/3b Clinical Trials." Open Forum Infectious Diseases 13, no. 5 (2026): 1. https://doi.org/10.1093/ofid/ofag265.
MLA (9th ed.) CitationPost, Frank A., et al. "Renal Outcomes in People With HIV-1 and Renal Impairment Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide: Integrated Analysis From 9 Phase 3/3b Clinical Trials." Open Forum Infectious Diseases, vol. 13, no. 5, 2026, p. 1, https://doi.org/10.1093/ofid/ofag265.